Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 6/1998

01-06-1998 | Review Article

Drug Therapy in Haemodialysis Patients

Special Considerations in the Elderly

Authors: Dr Wendy L. St Peter, Jennifer L. Clark, Ondrea M. Levos

Published in: Drugs & Aging | Issue 6/1998

Login to get access
Metadata
Title
Drug Therapy in Haemodialysis Patients
Special Considerations in the Elderly
Authors
Dr Wendy L. St Peter
Jennifer L. Clark
Ondrea M. Levos
Publication date
01-06-1998
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 6/1998
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-199812060-00003

Other articles of this Issue 6/1998

Drugs & Aging 6/1998 Go to the issue

Review Article

Pathogenesis and Treatment of Glucocorticoid-Induced Osteoporosis

Review Article

α1-Antitrypsin

Review Article

Important Drug-Drug Interactions in the Elderly

Leading Article

The ELITE Study

Review Article

The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and Flutter

Adis Drug Evaluation

Pramipexole
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits